Correlation Engine 2.0
Clear Search sequence regions


  • all- trans retinoic acid (2)
  • BCOR (1)
  • case reports (1)
  • FIP1L1 (1)
  • FNDC3B (1)
  • fusion gene (2)
  • GTF2I (1)
  • humans (1)
  • IRF2BP2 (1)
  • leukemia (9)
  • myeloid leukemia (2)
  • NABP1 (1)
  • neoplasm proteins (2)
  • NuMA (1)
  • PRKAR1A (1)
  • STAT3 (1)
  • STAT5b (1)
  • TBLR1 (1)
  • ZBTB16 (1)
  • Sizes of these terms reflect their relevance to your search.

    Acute promyelocytic leukemia (APL) is a special disease entity of acute myeloid leukemia (AML). The clinical use of all-trans retinoic acid (ATRA) has transformed APL into the most curable form of AML. The majority of APL cases are characterized by the fusion gene PML-RARA. Although the PML-RARA fusion gene can be detected in almost all APL cases, translocation variants of APL have been reported. To date, this is the most comprehensive review of these translocations, discussing 15 different variants. Reviewed genes involved in APL variants include: ZBTB16, NPM, NuMA, STAT5b, PRKAR1A, FIP1L1, BCOR, NABP1, TBLR1, GTF2I, IRF2BP2, FNDC3B, ADAMDTS17, STAT3, and TFG. The genotypic and phenotypic features of APL translocations are summarized. All reported studies were either case reports or case series indicating the rarity of these entities and limiting the ability to drive conclusions regarding their characteristics. However, reported variants have shown variable clinical and morphological features, with diverse responsiveness to ATRA. Copyright © 2020 King Faisal Specialist Hospital & Research Centre. Published by Elsevier Ltd. All rights reserved.

    Citation

    Abdul Mannan, Ibrahim N Muhsen, Eva Barragán, Miguel A Sanz, Mohamad Mohty, Shahrukh K Hashmi, Mahmoud Aljurf. Genotypic and Phenotypic Characteristics of Acute Promyelocytic Leukemia Translocation Variants. Hematology/oncology and stem cell therapy. 2020 Dec;13(4):189-201

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32473106

    View Full Text